Login / Signup

Change over Time in the Risk of Death among Japanese COVID-19 Cases Caused by the Omicron Variant Depending on Prevalence of Sublineages.

Yuki TakahashiHideo TanakaYoshitaka KogaShunichi TakiguchiShigeru OgimotoShizuyo InabaHiroyuki MatsuokaYuka MiyajimaTakeshi TakagiFujiko IrieYoshihito BambaFuyo YoshimiTomoyuki SuzukiIsao ArakiChika ShiraiSayuri MatsumotoMotoyuki ShimizuToshiyuki ShibataHitomi NagaiMasaru KinoshitaRie FujitaTsuyoshi Ogata
Published in: International journal of environmental research and public health (2023)
To assess temporal changes to the risk of death in COVID-19 cases caused by the Omicron variant, we calculated age-standardized case fatality rates (CFR) in patients aged ≥40 years over nine diagnostic periods (3 January to 28 August 2022) in ten Japanese prefectures (14.8 million residents). Among 552,581 study subjects, we found that there were 1836 fatalities during the isolation period (up to 28 days from date of onset). The highest age-standardized CFR (0.85%, 95% confidence interval (CI):0.78-0.92) was observed in cases diagnosed in the second 4-week period (January 31 to February 27), after which it declined significantly up to the 6th 4-week period (0.23%, 95% CI: 0.13-0.33, May 23 to June 19). The CFR then increased again but remained at 0.39% in the eighth period (July 18 to August 28). The CFR in cases with the BA.2 or BA.5 sublineages in the age range 60-80 years was significantly lower than that with BA.1 infections (60 years: 0.19%, 0.02%, 0.053%, respectively; 70 years: 0.91%, 0.33%, 0.39%; ≥80 years: 3.78%, 1.96%, 1.81%, respectively). We conclude that the risk of death in Japanese COVID-19 patients infected with Omicron variants declined through February to mid-June 2022.
Keyphrases
  • sars cov
  • coronavirus disease
  • end stage renal disease
  • ejection fraction
  • prognostic factors
  • risk factors
  • randomized controlled trial
  • peritoneal dialysis
  • dna methylation
  • gene expression
  • clinical trial
  • copy number